The investigation carried out by Banday et al. (2022) provided compelling evidence of the substantial influence of rs10774671 on the expression of OAS1, a crucial antiviral protein involved in the eradication of SARS-CoV-2, and its overall impact on the hospitalization outcomes of individuals with COVID-19 [86]. This evidence concerns the gene OAS1 and COVID-19.